Apollo Hospitals stock: Board meeting sets November 4 results date for Apollo Hospitals stock

Published on 10/21/2026 at 16:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q1 FY27 revenue rose 21.00 percent. Apollo Hospitals stock stood at INR 7,600.00 on October 21, 2026, down 1.30 percent from INR 7,700.00.

Reporting date November 4, 2026

Apollo Hospitals scheduled its next results board meeting for November 4, 2026, according to an October 12, 2026 filing.
Q1 FY27 revenue rose 21.00 percent to INR 70.44 billion on August 14, 2026.
Apollo Hospitals stock stood at INR 7,600.00 on October 21, 2026, down 1.30 percent from INR 7,700.00.
The stock traded at a price to earnings ratio of 52.30 and a market capitalization of INR 1.1 trillion.

Apollo Hospitals, INE437A01024, Illustration mit AI erstellt.

Apollo Hospitals Enterprise Limited (ISIN INE437A01024) has set November 4, 2026, for a board meeting to approve results for the quarter and six months ended September 30, 2026, according to Stockfin on October 12, 2026. The stock last traded at INR 7,600.00 on the NSE on October 21, 2026 at 3:29 p.m. IST, down 1.30 percent versus the prior close of INR 7,700.00.

Q2 results date is set

The November 4 meeting covers unaudited results for the three and six months ended September 30, 2026. An investor conference call is scheduled for November 5, 2026 at 3:00 p.m. IST, according to Stockfin. The dates give the market a defined checkpoint for hospital demand, pharmacy integration and digital-health costs.

Revenue growth meets valuation

Apollo Hospitals reported consolidated Q1 FY27 revenue of INR 70.44 billion, up 21.00 percent year on year, while EBITDA increased 28.00 percent to INR 10.92 billion, according to DSIJ in its August 14, 2026 report. Adjusted profit after tax rose 34.00 percent to INR 5.81 billion, and the EBITDA margin expanded to 15.50 percent from the prior-year level.

The same report said hospital revenue grew 22.00 percent year on year and hospital EBITDA increased 20.00 percent to INR 8.60 billion in Q1 FY27. Occupancy rose 5.00 percentage points year on year to 70.00 percent, giving investors an operating measure to watch alongside consolidated earnings.

Stock position and valuation

At INR 7,600.00 on October 21, 2026, Apollo Hospitals was 16.21 percent below its 52-week high of INR 9,070.50 and 13.50 percent above its 52-week low of INR 6,696.50. Its market capitalization was INR 1.1 trillion, with a price to earnings ratio of 52.30 and volume of 266,365 shares on the NSE.

Comparison with peers

Apollo Hospitals: down 1.30 percent, P/E 52.30, market capitalization INR 1.1 trillion.

Dr. Lal PathLabs (NSE, INR): down 0.41 percent, P/E 56.67, market capitalization INR 307.0 billion.

Max Healthcare (NSE, INR): down 1.22 percent, P/E 54.99, market capitalization INR 798.0 billion.

What comes next for investors

The November reporting date places the September quarter at the center of the next valuation test. The latest operating figures combined 21.00 percent revenue growth with a 15.50 percent EBITDA margin, while the share price remained 16.21 percent below its yearly high.

Price and dates

Apollo Hospitals stock last traded at INR 7,600.00 on the NSE on October 21, 2026 at 3:29 p.m. IST, down 1.30 percent from INR 7,700.00. The next scheduled board meeting is November 4, 2026, followed by the investor conference call on November 5, 2026 at 3:00 p.m. IST.